Theratechnologies Inc. (NASDAQ: THTX)
$1.9950
N/A ( -0.25% ) 63.6K
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Market Data
Open
$1.9950
Previous close
$1.9950
Volume
63.6K
Market cap
$88.28M
Day range
$1.8750 - $2.0240
52 week range
$1.0800 - $2.1800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 4 | Oct 10, 2024 |
| 6-k | Form 6-K | 2 | Sep 25, 2024 |
| 6-k | Form 6-K | 3 | Sep 18, 2024 |
| 6-k | Form 6-K | 4 | Jul 10, 2024 |
| 6-k | Form 6-K | 6 | Jul 10, 2024 |
| 6-k | Form 6-K | 3 | May 10, 2024 |
| 6-k | Form 6-K | 3 | May 09, 2024 |
| 6-k | Form 6-K | 19 | Apr 15, 2024 |
| 6-k | Form 6-K | 4 | Apr 10, 2024 |
| 6-k | Form 6-K | 6 | Apr 10, 2024 |